Milla Pharmaceutical Inc., a subsidiary of the Alter Pharma Group, is now becoming an A.forall company - The Alter Pharma Group, a group of generic and pharmacy sales companies, is rebranding all its brands and businesses into A.forall ... Milla Pharmaceuticals, now an A.forall company, is proud to be part of this transition ... HEALTH PHARMACEUTICAL.
The pharmaceutical industry's discovery of highly effective GABAergic agent medications for dystonia treatment is further driving the growth of this segment ... The pharmaceutical industry's global research and development efforts are expected to enhance the effectiveness of dystonia drugs, further driving market growth ... HEALTH PHARMACEUTICAL. SOURCE.
27, 2023 /PRNewswire/ -- The pharmaceutical industry demands precision and reliability in its supply chains to ensure the availability of life-saving medications ...ClientOverview.�Our client, a leading pharmaceutical company, grappled with delayed API deliveries and regulatory non-compliance among some API suppliers ... SOURCE SpendEdge.
"We are therefore pleased to have initiated this Phase 3 pivotal clinical trial of Cantex's azeliragon to determine its effect on preventing the kidney and lung complications that are a major source of morbidity and mortality from severe COVID-19 infection." ... About Cantex Pharmaceuticals, Inc ... SOURCE Cantex Pharmaceuticals, Inc.
This significant growth is driven by the increasing adoption of controlled release formulations by pharmaceutical companies seeking to combat generic competition ... ResearchAndMarkets.com is the world's leading source for international market research reports and market data ... HEALTH PHARMACEUTICAL. SOURCE.
Cheng will support pharmaceutical clients in ... "With her impressive academic background and over a decade of experience working with the pharmaceutical industry, she excels at sourcing viable, high-grade data to assess the safety of medications ... SOURCE Berkeley Research Group, LLC.
Prospection also brings deep technology- and pharmaceutical-industry experience to its Board of Directors with the appointment of Craig Jones as its Chairperson and Bruce Goodwin as a Non-Executive Director... Prospection pioneers patient-centric intelligence, illuminating patient care’s impact on market share for pharmaceutical brands ... SOURCE.
27, 2023 /PRNewswire/ -- Azurity Pharmaceuticals, Inc.�("Azurity") is pleased to announce the closing of its acquisition of Slayback Pharma LLC ("Slayback") today from existing investors including KKR, a leading global investment firm, and Everstone Capital... About Azurity Pharmaceuticals. ... SOURCE Azurity Pharmaceuticals.
Based in Gilbert, Arizona, CEM is a provider of controlled environment testing, validation, certification, and calibration services required in high-performance, regulated pharmaceutical, biotechnology, and healthcare settings ...View source version on businesswire.com.https.//www.businesswire.com/news/home/20230927435382/en/ ... SOURCE.
Rest assured, all information is rigorously sourced, with 107 scientific references, including conference abstracts, posters, presentations, full papers, and hyperlinks to corporate sources such as press releases, presentations, annual reports, SEC disclosures, and website content ... 9.3.5Jiangsu Hengrui Pharmaceuticals ... 9.4.9 Qilu Pharmaceutical.
About Venatorx Pharmaceuticals, Inc. Venatorx is a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with difficult-to-treat drug resistant gram-negative bacterial infections and viral infections ...View source version on businesswire.com.https.//www.businesswire.com/news/home/20230927557949/en/ ... SOURCE.
View the full release here ... is a pharmaceutical company based in Vancouver, BC, commercializing the multi-faceted antimicrobial properties of a liquid producing nitric oxide ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20230925232677/en/ ... HEALTH CLINICAL TRIALS RESEARCH PHARMACEUTICAL SCIENCE BIOTECHNOLOGY. SOURCE ... .